Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person1
Royalty Pharma plc
Company
Primary record17
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-11-06.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-11-06.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-11-06.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-11-06.
FMR LLC filed SCHEDULE 13G/A
0000315066-26-002829.txt : 20261105 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000315066-21-001225 0000315066 XXXXXXXX LIVE 7 CLASS A COMMON STOCK 09/30/2026 0001802768 ROYALTY PHARMA PLC G7709Q104 110 East 5
Royalty Pharma plc filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, Royalty Pharma plc issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of the press relea
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-10-05.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-09-30.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-09-30.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-09-24.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-08-19.
Royalty Pharma plc filed SCHEDULE 13D/A
(the "SEC") on May 23, 2025 (the "Original Schedule 13D" and, as amended by this Amendment, the "Schedule 13D") by the Reporting Persons relating to the Class A ordinary shares, par value $0.0001 per share (the "Class A
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-08-17.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-08-07.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-08-07.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-08-07.
Royalty Pharma plc filed 4
SEC form 4 filed by Royalty Pharma plc (CIK 1802768) on 2026-08-07.